Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, USA.
Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Matrix Biol. 2018 Aug;68-69:355-365. doi: 10.1016/j.matbio.2018.03.015. Epub 2018 Mar 19.
Endoplasmic reticulum (ER) stress is associated with development and progression of fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). ER stress was first implicated in the pathogenesis of IPF >15 years ago with the discovery of disease-causing mutations in surfactant protein C, which result in a misfolded gene product in type II alveolar epithelial cells (AECs). ER stress and the unfolded protein response (UPR) have been linked to lung fibrosis through regulation of AEC apoptosis, epithelial-mesenchymal transition, myofibroblast differentiation, and M2 macrophage polarization. Although progress has been made in understanding the causes and consequences of ER stress in IPF and a number of chronic fibrotic disorders, further studies are needed to identify key factors that induce ER stress in important cell types and define critical down-stream processes and effector molecules that mediate ER stress-related phenotypes. This review discusses potential causes of ER stress induction in the lungs and current evidence linking ER stress to fibrosis in the context of individual cell types: AECs, fibroblasts, and macrophages. As our understanding of the relationship between ER stress and lung fibrosis continues to evolve, future studies will examine new strategies to modulate UPR pathways for therapeutic benefit.
内质网(ER)应激与纤维化疾病的发展和进展有关,包括特发性肺纤维化(IPF)。15 年前,人们首次发现表面活性剂蛋白 C 的致病突变与 IPF 的发病机制有关,这些突变导致 II 型肺泡上皮细胞(AEC)中的基因产物错误折叠。内质网应激和未折叠蛋白反应(UPR)通过调节 AEC 凋亡、上皮-间充质转化、肌成纤维细胞分化和 M2 巨噬细胞极化与肺纤维化有关。尽管在理解 IPF 和许多慢性纤维化疾病中 ER 应激的原因和后果方面已经取得了进展,但仍需要进一步研究以确定诱导重要细胞类型中 ER 应激的关键因素,并确定介导 ER 应激相关表型的关键下游过程和效应分子。这篇综述讨论了肺中 ER 应激诱导的潜在原因,并根据单个细胞类型:AEC、成纤维细胞和巨噬细胞,讨论了 ER 应激与纤维化之间的现有证据联系。随着我们对内质网应激与肺纤维化之间关系的理解不断发展,未来的研究将探讨新的策略来调节 UPR 途径以获得治疗益处。